Clinical Trial

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

Study acronym: MIRAS

Recruiting

Summary

This trial is a translational, open-label, multi-sites, prospective and retrospective cohort study of 500 patients aimed at clinical and biological characterization of sarcoma of rare subtype. 400 patients will be included in this prospective cohort study; they will be identified in the investigating centers in the context of either routine care or a clinical study protocol. Retrospective cases of patients (100 cases in total) will be identified in all centers through the GSF/GETO clinical databases already setted up (including the clinical base Conticabase).

Protocol Amendment History 20 amendments

This ClinicalTrials.gov record has been amended 20 times since 2019-05-27; most recent amendment 2026-02-09.

Status change: Not Yet Recruiting → Recruiting 2021-02-24

Trial Details

NCT Number	NCT03967834
Lead Sponsor	Institut Claudius Regaud
Conditions	Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma, Perivascular Epithelioid Cell Neoplasms, Desmoplastic Small Round Cell Tumor, Malignant Solitary Fibrous Tumors, Alveolar Soft Part Sarcoma, Epithelioid Hemangioendothelioma +2 more
Enrollment	400 participants
Start Date	2021-04-26
Primary Completion	2031-04 (estimated)
Study Completion	2031-04 (estimated)
Updated on ClinicalTrials.gov	2026-02-10